Search results for: revocation
Showing results 21 - 28 of 28
Article
GJE Partner, Arnie Clarke, Leads Successful Landmark Opposition Attack of Teva’s Key 2030 Patent (EP 2 949 335) On Behalf of Mylan
Arnie Clarke has recently been involved in the ground-breaking appeal relating to Teva’s key 2030 patent (EP 2 949 335). Acting on behalf of Mylan, in front of the EPO board of appeal 3.3.04, ...
Legal Update
Santen: A Clear View of Drug Repurposing and a Loss of Sleep for Those Relying on Neurim
The CJEU has dealt a massive blow to the drug repurposing sector with its decision in Santen, stripping companies of their right to Supplementary Protection Certificates (SPCs), and overturning one of...